Global Nonalcoholic Steatohepatitis Drugs Pipeline Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

Segmented by Drug Class;

Drugs Targeting Metabolic Homeostasis, Drugs Acting on Insulin Resistance, Drugs to Prevent and Treat Inflammation and Drugs Preventing Oxidative Stress or Fibrosis.

Segmented by Mechanism;

Farnesoid X receptor Modulation, Peroxisome proliferator-activated receptor agonist, C chemokine receptor Antagonist, Apoptosis signal-regulated kinase-1 inhibitor, Oral acetyl-CoA carboxylase (ACC) inhibitor, Fibroblast growth factor 21 (FGF 21) inhibitor and Others.

Segmented by Development Phase;

Discovery, Preclinical, Phase 1 CT, Phase 2 CT, Phase 3 CT and IND/CTA Filed.

Segmented by Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2018 - 2028).
Report ID: Rn146532323 Published Date: September, 2022 Updated Date: October, 2022

Introduction

Global Nonalcoholic Steatohepatitis Drugs Pipeline Market (USD Million), 2018 - 2028

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
# Global Market (USD Million), 2018 - 2028
2018 69.6
2019 78.5
2020 82.9
2021 96.3
2022 104.6
2023 116.1
2024 136.7
2025 152.7
2026 177.3
2027 197.0
2028 201.1

In the year 2021, the Global Nonalcoholic Steatohepatitis Drugs Pipeline Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Drug Class
    2. Market Snapshot, By Mechanism
    3. Market Snapshot, By Development Phase
    4. Market Snapshot, By Region
    5. Market Opportunity Map
  4. Global Nonalcoholic Steatohepatitis Drugs Pipeline Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
      2. Restraints
      3. Opportunities
    2. Regulatory Scenario
    3. Reimbursement Scenario
    4. Mergers & Acquisitions, Collaborations & Partnerships, Agreements
    5. Pipeline Analysis/Technological Advancements
    6. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    7. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bragaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Industry Rivalry
  5. Market Segmentation
    1. Global Nonalcoholic Steatohepatitis Drugs Pipeline Market, By Drug Class, 2020 - 2030 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Segment Trends
        1. Drugs Targeting Metabolic Homeostasis
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        2. Drugs Acting on Insulin Resistance
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        3. Drugs to Prevent and Treat Inflammation
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        4. Drugs Preventing Oxidative Stress or Fibrosis
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
    2. Global Nonalcoholic Steatohepatitis Drugs Pipeline Market, By Mechanism, 2020 - 2030 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Segment Trends
        1. Farnesoid X receptor Modulation
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        2. Peroxisome proliferator-activated receptor agonist
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        3. C chemokine receptor Antagonist
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        4. Apoptosis signal-regulated kinase-1 inhibitor
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        5. Oral acetyl-CoA carboxylase (ACC) inhibitor
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        6. Fibroblast growth factor 21 (FGF 21) inhibitor
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        7. Others
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
    3. Global Nonalcoholic Steatohepatitis Drugs Pipeline Market, By Development Phase, 2020 - 2030 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Segment Trends
        1. Discovery
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        2. Preclinical
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        3. Phase 1 CT
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        4. Phase 2 CT
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        5. Phase 3 CT
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        6. IND/CTA Filed
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
    4. Global Nonalcoholic Steatohepatitis Drugs Pipeline Market, By Geography, 2020 - 2030 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Regional Trends
        1. North America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Mechanism, 2018 - 2028 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2018 - 2028 (USD Million)
            1. United States
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Mechanism, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2018 - 2028 (USD Million)
            2. Canada
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Mechanism, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2018 - 2028 (USD Million)
        2. Europe
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Mechanism, 2018 - 2028 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2018 - 2028 (USD Million)
            1. Germany
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Mechanism, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2018 - 2028 (USD Million)
            2. United Kingdom
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Mechanism, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2018 - 2028 (USD Million)
            3. France
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Mechanism, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2018 - 2028 (USD Million)
            4. Italy
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Mechanism, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2018 - 2028 (USD Million)
            5. Spain
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Mechanism, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2018 - 2028 (USD Million)
            6. Rest of Europe
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Mechanism, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2018 - 2028 (USD Million)
        3. Asia Pacific
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Mechanism, 2018 - 2028 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2018 - 2028 (USD Million)
            1. Japan
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Mechanism, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2018 - 2028 (USD Million)
            2. China
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Mechanism, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2018 - 2028 (USD Million)
            3. India
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Mechanism, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2018 - 2028 (USD Million)
            4. Australia & New Zealand
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Mechanism, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2018 - 2028 (USD Million)
            5. South Korea
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Mechanism, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2018 - 2028 (USD Million)
            6. ASEAN (Association of South East Asian Countries)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Mechanism, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2018 - 2028 (USD Million)
            7. Rest of Asia Pacific
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Mechanism, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2018 - 2028 (USD Million)
        4. Latin America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Mechanism, 2018 - 2028 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2018 - 2028 (USD Million)
            1. Brazil
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Mechanism, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2018 - 2028 (USD Million)
            2. Mexico
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Mechanism, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2018 - 2028 (USD Million)
            3. Argentina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Mechanism, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2018 - 2028 (USD Million)
            4. Rest of Latin America
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Mechanism, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2018 - 2028 (USD Million)
        5. Middle East & Africa
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Mechanism, 2018 - 2028 (USD Million)
          4. Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2018 - 2028 (USD Million)
            1. GCC
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Mechanism, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2018 - 2028 (USD Million)
            2. Israel
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Mechanism, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2018 - 2028 (USD Million)
            3. South Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Mechanism, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2018 - 2028 (USD Million)
            4. Rest of Middle East & Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Mechanism, 2018 - 2028 (USD Million)
              4. Market Size and Forecast, and Y-o-Y Growth, By Development Phase, 2018 - 2028 (USD Million)
  6. Competitive Landscape
    1. Heat Map Analysis
    2. Company Profiles
      1. Tobira Therapeutics, Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      2. Genfit SA
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      3. Intercept Pharmaceuticals Inc.,
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      4. Gilead Sciences, Inc
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      5. Bristol-Mayers Squibb and Comnay
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      6. Merck KGaA
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      7. NGM Biopharmaceuticals
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      8. Galectin Therapeutics Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
  7. Analyst Views
  8. Future Outlook of the Market

ReAnIn's Most Viewed Titles:

Healthcare Pharmaceuticals & Therapeutics Non-invasive Aesthetic Treatment
Global Non-invasive Aesthetic Treatment Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Non-invasive Aesthetic Treatment Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Healthcare IT Non-Destructive Medical Technologies
Global Non-Destructive Medical Technologies Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Non-Destructive Medical Technologies Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Medical Devices Non-Hospital-Based Point-Of-Care Diagnostic Products
Global Non-Hospital-Based Point-Of-Care Diagnostic Products Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Non-Hospital-Based Point-Of-Care Diagnostic Products Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Non-Hyaluronic Acid Dermal Filler
Global Non-Hyaluronic Acid Dermal Filler Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Non-Hyaluronic Acid Dermal Filler Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...